THIS NEW PROSPECT FOR WEIGHT REGULATION?

Researchers are excitedly examining retatrutide, a promising treatment created by Eli Lilly, as a potential step in weight management. Distinct from many existing approaches, retatrutide is a dual -action agonist targeting both GLP-1 and GIP, chemicals that affect appetite and glucose control . P